A variant endpoint in cancer research refers to an alternative outcome measure used in clinical trials to assess the effectiveness of a treatment. Instead of relying solely on traditional endpoints such as overall survival (OS) or progression-free survival (PFS), variant endpoints may include measures like tumor response rate, duration of response, and biomarker changes. These endpoints can provide more nuanced insights into how a treatment impacts the disease.
